Chemoinformaics analysis of 3,4-Dihydroexcelsin
Molecular Weight | 496.597 | nRot | 4 |
Heavy Atom Molecular Weight | 456.277 | nRig | 25 |
Exact Molecular Weight | 496.267 | nRing | 5 |
Solubility: LogS | -3.872 | nHRing | 2 |
Solubility: LogP | 3.257 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 26 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
nHA | 9 | APOL | 77.3097 |
nHD | 4 | BPOL | 47.0723 |
QED | 0.419 |
Synth | 6.662 |
Natural Product Likeliness | 3.344 |
NR-PPAR-gamma | 0.039 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.543 |
Pgp-sub | 0.996 |
HIA | 0.053 |
CACO-2 | -5.289 |
MDCK | 0.000105798 |
BBB | 0.07 |
PPB | 0.764586 |
VDSS | 0.846 |
FU | 0.222644 |
CYP1A2-inh | 0.015 |
CYP1A2-sub | 0.85 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.702 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.017 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.113 |
CYP3a4-inh | 0.068 |
CYP3a4-sub | 0.196 |
CL | 5.536 |
T12 | 0.589 |
hERG | 0.244 |
Ames | 0.011 |
ROA | 0.289 |
SkinSen | 0.16 |
Carcinogencity | 0.012 |
EI | 0.011 |
Respiratory | 0.918 |
NR-Aromatase | 0.462 |
Antiviral | Yes |
Prediction | 0.762212 |